Cargando…

Investigation of TG-43 Dosimetric Parameters for (192)Ir Brachytherapy Source Using GATE Monte Carlo Code

PURPOSE: According to the revised Task Group number 43 recommendations, a brachytherapy source must be validated against a similar or identical source before its clinical application. The purpose of this investigation is to verify the dosimetric data of the high dose rate (HDR) BEBIG (192)Ir source...

Descripción completa

Detalles Bibliográficos
Autores principales: Joya, Musa, Nedaie, Hassan Ali, Geraily, Ghazale, Rezaei, Hadi, Bromand, Awaz, Ghorbani, Mahdi, Sheikhzadeh, Peyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642593/
https://www.ncbi.nlm.nih.gov/pubmed/37969149
http://dx.doi.org/10.4103/jmp.jmp_41_23
_version_ 1785146996965769216
author Joya, Musa
Nedaie, Hassan Ali
Geraily, Ghazale
Rezaei, Hadi
Bromand, Awaz
Ghorbani, Mahdi
Sheikhzadeh, Peyman
author_facet Joya, Musa
Nedaie, Hassan Ali
Geraily, Ghazale
Rezaei, Hadi
Bromand, Awaz
Ghorbani, Mahdi
Sheikhzadeh, Peyman
author_sort Joya, Musa
collection PubMed
description PURPOSE: According to the revised Task Group number 43 recommendations, a brachytherapy source must be validated against a similar or identical source before its clinical application. The purpose of this investigation is to verify the dosimetric data of the high dose rate (HDR) BEBIG (192)Ir source (Ir2.A85-2). MATERIALS AND METHODS: The HDR (192)Ir encapsulated seed was simulated and its main dosimetric data were calculated using Geant4 Application for Tomographic Emission (GATE) simulation code. Cubic cells were used for the calculation of dose rate constant and radial dose function while for anisotropy function ring cells were used. DoseActors were simulated and attached to the respective cells to obtain the required data. RESULTS: The dose rate constant was obtained as 1.098 ± 0.003 cGy.h − (1).U − (1), differing by 1.0% from the reference value reported by Granero et al. Similarly, the calculated values for radial dose and anisotropy functions presented good agreement with the results obtained by Granero et al. CONCLUSION: The results of this study suggest that the GATE Monte Carlo code is a valid toolkit for benchmarking brachytherapy sources and can be used for brachytherapy simulation-based studies and verification of brachytherapy treatment planning systems.
format Online
Article
Text
id pubmed-10642593
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-106425932023-11-15 Investigation of TG-43 Dosimetric Parameters for (192)Ir Brachytherapy Source Using GATE Monte Carlo Code Joya, Musa Nedaie, Hassan Ali Geraily, Ghazale Rezaei, Hadi Bromand, Awaz Ghorbani, Mahdi Sheikhzadeh, Peyman J Med Phys Original Article PURPOSE: According to the revised Task Group number 43 recommendations, a brachytherapy source must be validated against a similar or identical source before its clinical application. The purpose of this investigation is to verify the dosimetric data of the high dose rate (HDR) BEBIG (192)Ir source (Ir2.A85-2). MATERIALS AND METHODS: The HDR (192)Ir encapsulated seed was simulated and its main dosimetric data were calculated using Geant4 Application for Tomographic Emission (GATE) simulation code. Cubic cells were used for the calculation of dose rate constant and radial dose function while for anisotropy function ring cells were used. DoseActors were simulated and attached to the respective cells to obtain the required data. RESULTS: The dose rate constant was obtained as 1.098 ± 0.003 cGy.h − (1).U − (1), differing by 1.0% from the reference value reported by Granero et al. Similarly, the calculated values for radial dose and anisotropy functions presented good agreement with the results obtained by Granero et al. CONCLUSION: The results of this study suggest that the GATE Monte Carlo code is a valid toolkit for benchmarking brachytherapy sources and can be used for brachytherapy simulation-based studies and verification of brachytherapy treatment planning systems. Wolters Kluwer - Medknow 2023 2023-09-18 /pmc/articles/PMC10642593/ /pubmed/37969149 http://dx.doi.org/10.4103/jmp.jmp_41_23 Text en Copyright: © 2023 Journal of Medical Physics https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Joya, Musa
Nedaie, Hassan Ali
Geraily, Ghazale
Rezaei, Hadi
Bromand, Awaz
Ghorbani, Mahdi
Sheikhzadeh, Peyman
Investigation of TG-43 Dosimetric Parameters for (192)Ir Brachytherapy Source Using GATE Monte Carlo Code
title Investigation of TG-43 Dosimetric Parameters for (192)Ir Brachytherapy Source Using GATE Monte Carlo Code
title_full Investigation of TG-43 Dosimetric Parameters for (192)Ir Brachytherapy Source Using GATE Monte Carlo Code
title_fullStr Investigation of TG-43 Dosimetric Parameters for (192)Ir Brachytherapy Source Using GATE Monte Carlo Code
title_full_unstemmed Investigation of TG-43 Dosimetric Parameters for (192)Ir Brachytherapy Source Using GATE Monte Carlo Code
title_short Investigation of TG-43 Dosimetric Parameters for (192)Ir Brachytherapy Source Using GATE Monte Carlo Code
title_sort investigation of tg-43 dosimetric parameters for (192)ir brachytherapy source using gate monte carlo code
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642593/
https://www.ncbi.nlm.nih.gov/pubmed/37969149
http://dx.doi.org/10.4103/jmp.jmp_41_23
work_keys_str_mv AT joyamusa investigationoftg43dosimetricparametersfor192irbrachytherapysourceusinggatemontecarlocode
AT nedaiehassanali investigationoftg43dosimetricparametersfor192irbrachytherapysourceusinggatemontecarlocode
AT gerailyghazale investigationoftg43dosimetricparametersfor192irbrachytherapysourceusinggatemontecarlocode
AT rezaeihadi investigationoftg43dosimetricparametersfor192irbrachytherapysourceusinggatemontecarlocode
AT bromandawaz investigationoftg43dosimetricparametersfor192irbrachytherapysourceusinggatemontecarlocode
AT ghorbanimahdi investigationoftg43dosimetricparametersfor192irbrachytherapysourceusinggatemontecarlocode
AT sheikhzadehpeyman investigationoftg43dosimetricparametersfor192irbrachytherapysourceusinggatemontecarlocode